Spleen-tonifying and kidney-warming pellets for treating ankylosing spondylitis

Abstract

The invention discloses spleen-tonifying and kidney-warming pellets for treating ankylosing spondylitis. The spleen-tonifying and kidney-warming pellets for treating ankylosing spondylitis are mainly prepared from the following raw material medicines: 60-80 parts of bighead atractylodes rhizome, 30-45 parts of radix aconite, 50-70 parts of codonopsis pilosula, 20-40 parts of fructus corni, 70-90 parts of eucommia ulmoides, 30-50 parts of prepared rehmannia root, 30-50 parts of poria cocos, 30-50 parts of medicinal cyathula root, 30-50 parts of liquorice, 30-50 parts of baked ginger, 20-30 parts of cinnamon, 30-50 parts of herba epimedii, 20-30 parts of cornua cervi pantotrichum, 50-70 parts of rhizoma cibotii, 70-90 parts of medlar, 40-60 parts of salvia miltiorrhiza, 30-50 parts of ligusticum wallichii, 50-70 parts of teasel root, 50-70 parts of Chinese yam, 50-70 parts of angelica sinensis and 30-50 parts of astragalus membranaceus. The product disclosed by the invention is short in treatment time, free from side effects and remarkable in efficacy in treatment on ankylosing spondylitis, and good in efficacy on arthralgia as well as rheumatism and rheumatoid arthritis due to spleen-kidney-yang deficiency.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a Jianpi Wenshen pill for treating ankylosing spondylitis. Background technique [0002] Ankylosing spondylitis is a systemic, chronic, autoimmune disease of unknown etiology. Lesions primarily involve the sacrohip joints and spine, causing ankylosis and fibrosis. In most patients, the sacrohip joint is first affected, and then develops upward to the cervical spine, manifested as recurrent lumbosacral pain, low back pain, and a sense of stiffness, especially in the morning, limited lumbar mobility, late spine stiffness, and spinal kyphosis Deformity, some patients can affect the peripheral joints, affecting the hip joint can cause femoral head necrosis. The onset of this disease is hidden, the first symptoms are changeable, lack of specificity, it is easy to be misdiagnosed and delay treatment, and severe cases can cause human deformity and disability, whi...

AI Technical Summary

Problems solved by technology

Non-steroidal anti-inflammatory drugs, as traditional therapeutic drugs, have played an active role in the treatment and improvement of the quality of life of patients, but the side effects of these drugs on the gastrointestinal tract and nephrotoxicity have greatly limited their clinical application

Chronically acting drugs have played a certain role in slowing down or preventing the development of the disease, but these drugs have many side effects, in addition to gastrointestinal reactions, there are nervous system, leukopenia, rash, bone marrow suppression, liver damage, lung lesions, etc. Adverse reactions

Although glucocorticoids have strong anti-inflammatory and analgesic effects, because they cannot well control the development of ankylosing spondylitis, cannot slow down the course of ankylosing spondylitis, and have many side effects, long-term use is more harmful than benefit, generally not for routine use

In recent years, new biological agents for the treatment of ankylosing spondylitis have been developed at home and abroad to alleviate and improve the condition, but due to factors such as infusion reactions, delayed allergic reactions, high infection rates, and high prices, clinical use is greatly limited

Surgical treatment adopts artificial total hip replacement, spinal vertebral osteotomy to correct the deformity and is an advanced patient. In addition, the risk after the operation is high, the price is expensive, the patient is painful, the healing is slow, and even disabled, it will form a situation of treating the symptoms but not the root cause. Disadvantages